|End-of-day quote - 01/20|
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 202104/30/2021 | 02:00am
Beximco Pharmaceuticals Limited announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced sales was BDT 7,362.303 million compared to BDT 6,610.063 million a year ago. Operating income was BDT 1,732.754 million compared to BDT 1,473.961 million a year ago. Net income was BDT 1,461.959 million compared to BDT 900.434 million a year ago. Basic earnings per share from continuing operations was BDT 3.28 compared to BDT 2.02 a year ago. For the nine months, sales was BDT 21,762.492 million compared to BDT 19,105.589 million a year ago. Operating income was BDT 5,199.622 million compared to BDT 4,231.855 million a year ago. Net income was BDT 3,670.643 million compared to BDT 2,606.853 million a year ago. Basic earnings per share from continuing operations was BDT 8.23 compared to BDT 5.84 a year ago.
© S&P Capital IQ 2022
All news about BEXIMCO PHARMACEUTICALS LIMITED